| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Aug 14, 2025 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -3,743 | -0.87% | ✓ | $51.7K |
| Jan 6, 2025 | Jan 8, 2025 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 20.0 | -15,162 | -3.80% | ✗ | $308.3K |
| Aug 20, 2024 | Aug 22, 2024 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -22,458 | -6.43% | ✓ | $549.9K |
| Aug 13, 2024 | Aug 15, 2024 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -2,337 | -0.66% | ✗ | $53.5K |
| Feb 13, 2024 | Feb 15, 2024 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 45.0 | -4,189 | -1.18% | ✓ | $73.1K |
| Jan 10, 2024 | Jan 12, 2024 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 45.0 | -4,668 | -1.29% | ✓ | $88.8K |
| Jan 5, 2024 | Jan 9, 2024 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -9,972 | -2.88% | ✗ | $193.8K |
| Aug 23, 2023 | Aug 25, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -2,522 | -0.86% | ✓ | $58.6K |
| Aug 21, 2023 | Aug 23, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -2,478 | -0.83% | ✗ | $56K |
| Aug 14, 2023 | Aug 16, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -2,768 | -0.92% | ✓ | $65.9K |
| Aug 10, 2023 | Aug 14, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -2,857 | -0.94% | ✗ | $69K |
| Feb 15, 2023 | Feb 17, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 52.5 | -1,476 | -0.49% | ✓ | $43.4K |
| Feb 10, 2023 | Feb 14, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -3,366 | -0.69% | ✓ | $101.1K |
| Feb 8, 2023 | Feb 10, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 43.8 | -1,521 | -0.49% | ✗ | $47K |
| Jan 9, 2023 | Jan 10, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 52.5 | -1,459 | -0.47% | ✓ | $41.6K |
| Jan 5, 2023 | Jan 9, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 45.0 | -4,087 | -1.30% | ✓ | $116.6K |
| Jan 3, 2023 | Jan 5, 2023 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 95.0 | +38,207 | 13.83% | ✗ | $83.6K |
| Aug 23, 2022 | Aug 25, 2022 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -2,424 | -0.87% | ✓ | $77.5K |
| Aug 19, 2022 | Aug 23, 2022 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -2,576 | -0.92% | ✗ | $85.6K |
| Feb 11, 2022 | Feb 15, 2022 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -2,918 | -1.12% | ✗ | $101.3K |
| Feb 9, 2022 | Feb 11, 2022 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -1,423 | -0.54% | ✗ | $52.8K |
| Jan 5, 2022 | Jan 7, 2022 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -2,845 | -1.07% | ✗ | $127.4K |
| Dec 6, 2021 | Dec 8, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 47.5 | -1,476 | -0.56% | ✓ | $62.8K |
| Aug 23, 2021 | Aug 25, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 38.8 | -6,143 | -2.53% | ✓ | $300.5K |
| Aug 19, 2021 | Aug 23, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -2,546 | -1.04% | ✗ | $126.2K |
| Mar 29, 2021 | Mar 31, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 45.0 | -2,822 | -1.14% | ✓ | $154.1K |
| Mar 1, 2021 | Mar 3, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 38.8 | -7,092 | -2.79% | ✓ | $470.7K |
| Feb 11, 2021 | Feb 16, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -3,156 | -1.22% | ✗ | $222K |
| Feb 7, 2021 | Feb 11, 2021 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -1,470 | -0.86% | ✗ | $109.8K |
| Jan 2, 2019 | Nov 30, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 42.5 | -17,500 | -1.82% | ✓ | $340.2K |
| Dec 3, 2018 | Nov 30, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -17,500 | -7.22% | ✓ | $322.8K |
| Nov 15, 2018 | Nov 30, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -17,500 | -7.22% | ✓ | $316.2K |
| Oct 8, 2020 | Oct 13, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 23.8 | -52,906 | -9.24% | ✓ | $2.2M |
| Sep 10, 2020 | Sep 14, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 41.3 | -3,689 | -2.19% | ✓ | $114.4K |
| Aug 20, 2020 | Aug 24, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -1,954 | -1.22% | ✗ | $64.2K |
| Mar 30, 2020 | Apr 1, 2020 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -1,428 | -1.31% | ✗ | $27.8K |
| Dec 19, 2019 | Dec 23, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 32.5 | -6,890 | -6.16% | ✓ | $137.8K |
| Aug 20, 2019 | Aug 22, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -2,834 | -1.80% | ✗ | $52.7K |
| Jul 8, 2019 | Jul 10, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17.5 | -17,500 | -16.57% | ✓ | $355K |
| Jun 10, 2019 | Jun 12, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17.5 | -17,500 | -16.14% | ✓ | $328.7K |
| May 8, 2019 | May 10, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 22.5 | -17,500 | -14.40% | ✓ | $399.9K |
| Apr 1, 2019 | May 10, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 12.5 | -36,912 | -22.50% | ✓ | $939K |
| Apr 4, 2019 | Apr 8, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -9,588 | -5.64% | ✓ | $252.7K |
| Apr 1, 2019 | Apr 3, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 12.5 | -36,805 | -22.47% | ✓ | $936.3K |
| Mar 14, 2019 | Mar 18, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 51.3 | -1,000 | -0.70% | ✓ | $25K |
| Mar 1, 2019 | Mar 5, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -17,500 | -9.28% | ✓ | $388K |
| Feb 1, 2019 | Feb 5, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -17,500 | -9.41% | ✓ | $327.6K |
| Jan 2, 2019 | Jan 4, 2019 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -14,502 | -8.54% | ✓ | $283.5K |
| Dec 3, 2018 | Dec 6, 2018 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -17,500 | -8.23% | ✓ | $322.8K |
| Nov 15, 2018 | Nov 19, 2018 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 26.3 | -17,500 | -7.60% | ✓ | $316.2K |
| Oct 1, 2018 | Oct 3, 2018 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -17,500 | -7.06% | ✓ | $380.1K |
| Sep 4, 2018 | Sep 6, 2018 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -17,500 | -6.60% | ✓ | $333.4K |
| Aug 29, 2018 | Aug 31, 2018 | Denali Therapeutics Inc. | Chief Medical Officer | Sell | 30.0 | -17,500 | -6.19% | ✓ | $315.7K |